HOT STOCKS HIGHLIGHTS - Jan. 26
NEW YORK, Jan. 26 (Reuters) - Stocks moving in U.S. markets on Friday included:
ART TECH GROUP (NasdaqNM:ARTG - news) JUMPED $9, OR 36 PERCENT, TO $34.
**The Internet software maker on Thursday posted fourth quarter net income of 10 cents a share, beating the 8 cents a share estimate by analysts polled by First Call/Thomson Financial.
The company said 131 companies became new users of its online customer relationship management and electronic commerce products and services.
SAWTEK INC. (NasdaqNM:SAWS - news) SLID $12-1/2, OR 32 PERCENT, TO $26.
**The wireless communications component maker on Thursday said it expected fiscal second quarter earnings to be roughly in line with the 29 cents a share in the year-ago period, much lower than the 43 cents expected by analysts polled by First Call/Thomson Financial.
The company cited a slowdown in the economy, lower prices and inventory build-up from the last quarter.
SAPIENT CORP. (NasdaqNM:SAPE - news) FELL $1-1/4, OR 8 PERCENT, TO $15-3/8.
**The Internet consultant on Thursday said it expected to meet the low end of Wall Street's expectations for 2001 earnings, which ranged between 48 cents and 53 cents per share.
Credit Suisse First Boston on Friday cut its 2001 earnings estimate for the company to 45 cents from 50 cents a share.
STARBUCKS CORP. (NasdaqNM:SBUX - news) SURGED $2, OR 5 PERCENT, TO $44-13/16.
**The Seattle-based coffee-shop giant on Thursday posted net earnings for the quarter ended Dec. 31 of 25 cents per diluted share, better than the 23 cents a share estimate by analysts polled by First Call/Thomson Financial, as it continued its rapid global expansion.
The company also raised its earnings per share goal for fiscal 2001 to 91 cents-93 cents from a previous target of 90 cents-92 cents.
DYCOM INDUSTRIES INC. (NYSE:DY - news) SLID $10-3/8, OR 33 PERCENT,
To $21.
**The provider of engineering and maintenance services to telecommunication companies on Thursday said it expected to report second quarter earnings of between 28 and 31 cents a share, much lower than the 39 cents a share estimate by analysts polled by First Call/Thomson Financial.
The company cited budgeting issues with customers for the lower guidance.
POZEN INC. (NasdaqNM:POZN - news) DROPPED $6-1/2, OR 50 PERCENT, TO $6-1/2.
**The North Carolina based drug development company with a portfolio of product candidates for the treatment of migraine, was the biggest decliner on the Nasdaq Stock Market in percentage terms.
The company said on Friday that the Food and Drug Administration (FDA) has requested additional carcinogenicity studies for MT 100, the company's late Phase III migraine treatment. POZEN had requested a complete waiver of any carcinogenicity studies.
Prior to Friday's drop the stock was down 25 percent |
